HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk

Blood

Volumn 120, Issue 15, 2012, Pages 3039-3047

  Urayama, Kevin Y ^a,b   Chokkalingam, Anand P ^a   Metayer, Catherine ^a   Ma, Xiaomei ^c   Selvin, Steve ^a   Barcellos, Lisa F ^a   Wiemels, Joseph L ^d   Wiencke, John K ^d   Taylor, Malcolm ^e   Brennan, Paul ^f   Dahl, Gary V ^g   Moonsamy, Priscilla ^h   Erlich, Henry A ^h   Trachtenberg, Elizabeth ⁱ   Buffler, Patricia A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Center for Clinical Epidemiology St Luke's Life Science Institute   (Japan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ROCHE MOLECULAR SYSTEMS   (United States)

ⁱ CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DP ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BREAST FEEDING; CANCER RISK; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DAY CARE; DISEASE ASSOCIATION; EAR INFECTION; ETHNICITY; FEMALE; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNOMODULATION; INFANCY; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN INTERACTION; RACE; RISK ASSESSMENT; SCHOOL CHILD; SIBLING;

EID: 84867800362     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-404723     Document Type: Article

References (48)

1. McNally RJ, Eden TO. An infectious aetiology for childhood acute leukaemia: a review of the evidence. Br J Haematol. 2004;127(3):243-263. (Pubitemid 39468939)
2. Penrose M. Cat leukemia. Br Med J. 1970; 1(5698):755.
3. Boxus M, Willems L. Mechanisms of HTLV-1 persistence and transformation. Br J Cancer. 2009; 101(9):1497-1501.
4. O'Connor SM, Boneva RS. Infectious etiologies of childhood leukemia: plausibility and challenges to proof. Environ Health Perspect. 2007;115(1): 146-150. (Pubitemid 46050297)
5. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193-203. (Pubitemid 43292563)
6. Marsh SG, Parham P, Barber LD. The HLA Facts Book. London, United Kingdom: Academic Press; 2000.
7. Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004. Tissue Antigens. 2004; 64(6):631-649. (Pubitemid 39628044)
8. Robinson J, Waller MJ, Parham P, et al. IMGT/ HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 2003;31(1):311-314. (Pubitemid 36150392)
9. Thorsby E. HLA associated diseases. Hum Immunol. 1997;53(1):1-11.
10. Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virusnegative Hodgkin's lymphoma. Lancet. 2005; 365(9478):2216-2224. (Pubitemid 40853915)
11. Urayama KY, Jarrett RF, Hjalgrim H, et al. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst. 2012;104(3):240-253.
12. Ooi EE, Ren EC, Chan SH. Association between microsatellites within the human MHC and nasopharyngeal carcinoma. Int J Cancer. 1997;74(2): 229-232. (Pubitemid 27234516)
13. Azuma T, Ito S, Sato F, et al. The role of the HLADQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer. 1998;82(6):1013-1018. (Pubitemid 28138079)
14. Arends MJ, Buckley CH, Wells M. Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol. 1998;51(2):96-103. (Pubitemid 28140721)
15. Dorak MT, Lawson T, Machulla HK, Darke C, Mills KI, Burnett AK. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia. Blood. 1999;94(2):694-700. (Pubitemid 29323883)
16. Dorak MT, Oguz FS, Yalman N, et al. A malespecific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leuk Res. 2002;26(7):651-656. (Pubitemid 34465701)
17. Klitz W, Gragert L, Trachtenberg E. Spectrum of HLA associations: the case of medically refractory pediatric acute lymphoblastic leukemia. Immunogenetics. 2012;64(6):409-419.
18. Taylor GM, Dearden S, Ravetto P, et al. Genetic susceptibility to childhood common acute lymphoblastic leukaemia is associated with polymorphic peptide-binding pocket profiles in HLADPB1*0201. Hum Mol Genet. 2002;11(14):1585- 1597.
19. Taylor GM, Hussain A, Lightfoot TJ, Birch JM, Eden TO, Greaves MF. HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes. Br J Cancer. 2008;98(6):1125-1131. (Pubitemid 351399803)
20. Taylor M, Harrison C, Eden T, et al. HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for prevention. Cancer Immunol Immunother. 2008;57(1):53-61. (Pubitemid 350043648)
21. Ma X, Buffler PA, Wiemels JL, et al. Ethnic difference in daycare attendance, early infections, and risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev. 2005;14(8): 1928-1934. (Pubitemid 41161202)
22. Urayama KY, Ma X, Selvin S, et al. Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer. 2011; 128(7):1632-1643.
23. Bartley K, Metayer C, Selvin S, Ducore J, Buffler P. Diagnostic X-rays and risk of childhood leukaemia. Int J Epidemiol. 2010;39(6):1628-1637.
24. Ma X, Buffler PA, Layefsky M, Does MB, Reynolds P. Control selection strategies in case-control studies of childhood diseases. Am J Epidemiol. 2004; 159(10):915-921. (Pubitemid 38608267)
25. Alexander FE, Patheal SL, Biondi A, et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 2001;61(6):2542-2546. (Pubitemid 32685836)
26. Hansen HM, Wiemels JL,Wrensch M, Wiencke JK. DNA quantification of whole genome amplified samples for genotyping on a multiplexed bead array platform. Cancer Epidemiol Biomarkers Prev. 2007;16(8):1686-1690. (Pubitemid 47294839)
27. Cano P, Klitz W, Mack SJ, et al. Common and well-documented HLA alleles: report of the Ad- Hoc Committee of the American Society for Histocompatiblity and Immunogenetics. Hum Immunol. 2007;68(5):392-417. (Pubitemid 46616982)
28. Aldrich MC, Zhang L, Wiemels JL, et al. Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California. Cancer Epidemiol Biomarkers Prev. 2006;15(3):578-581.
29. Castelli FA, Buhot C, Sanson A, et al. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. J Immunol. 2002;169(12):6928-6934. (Pubitemid 36899279)
30. Diaz G, Amicosante M, Jaraquemada D, et al. Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. Int Immunol. 2003;15(5):565-576. (Pubitemid 36519395)
31. Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G. PyPop update: a software pipeline for large-scale multilocus population genomics. Tissue Antigens. 2007;69(Suppl 1):192-197. (Pubitemid 46625883)
32. Begovich AB, Helmuth RC, Oksenberg JR, et al. HLA-DP beta and susceptibility to multiple sclerosis: an analysis of Caucasoid and Japanese patient populations. Hum Immunol. 1990;28(4):365- 372.
33. Moonsamy PV, KlitzW, Tilanus MG, Begovich AB. Genetic variability and linkage disequilibrium within the DP region in the CEPH families. Hum Immunol. 1997;58(2):112-121. (Pubitemid 28093582)
34. Noble JA, Valdes AM, Thomson G, Erlich HA. The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes. 2000;49(1): 121-125.
35. al-Daccak R,Wang FQ, Theophille D, Lethielleux P, Colombani J, Loiseau P. Gene polymorphism of HLA-DPB1 and DPA1 loci in Caucasoid population: frequencies and DPB1-DPA1 associations. Hum Immunol. 1991;31(4):277-285.
36. Eiermann TH, Fakler J, Muller CR, Ballas M, Goldmann SF. HLA-DPB1 oligonucleotide typing of a southwest German Caucasian population. Tissue Antigens. 1991;38(5):193-198.
37. Sage DA, Evans PR, Howell WM. HLA DPA1- DPB1 linkage disequilibrium in the British Caucasoid population. Tissue Antigens. 1994;44(5): 335-338. (Pubitemid 24343816)
38. Madden DR. The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol. 1995;13:587-622.
39. Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol. 1999;17:51-88. (Pubitemid 29241119)
40. Hall MA, Lanchbury JS, Ciclitira PJ. HLA class II region genes and susceptibility to dermatitis herpetiformis: DPB1 and TAP2 associations are secondary to those of the DQ subregion. Eur J Immunogenet. 1996;23(4):285-296. (Pubitemid 26254667)
41. Rosenberg WM, Wordsworth BP, Jewell DP, Bell JI. A locus telomeric to HLA-DPB encodes susceptibility to coeliac disease. Immunogenetics. 1989;30(4):307-310. (Pubitemid 19247525)
42. Rossman MD, Thompson B, Frederick M, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73(4):720-735. (Pubitemid 37271878)
43. M'Rabet L, Vos AP, Boehm G, Garssen J. Breastfeeding and its role in early development of the immune system in infants: consequences for health later in life. J Nutr. 2008;138(9):1782S-1790S.
44. Labbok MH, Clark D, Goldman AS. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol. 2004;4(7):565-572. (Pubitemid 38931771)
45. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol. 2001;1(1):69-75. (Pubitemid 33741977)
46. Dietert RR, Piepenbrink MS. The managed immune system: protecting the womb to delay the tomb. Hum Exp Toxicol. 2008;27(2):129-134.
47. Wing K, Fehervari Z, Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int Immunol. 2006;18(7):991- 1000.
48. Chokkalingam AP, Aldrich MC, Bartley K, et al. Matching on race and ethnicity in case-control studies as a means of control for population stratification. Epidemiology. 2011;1:101.